Recovering from COVID-19’s acute symptoms is only the beginning for many. From 10% to 30% of people who contract the coronavirus experience long COVID-19 symptoms for more than 12 weeks. Common post-viral long COVID-19 symptoms for these patients are fatigue, concentration difficulty, headache, muscle and joint aches, fever, sleeping difficulty, depression, anxiety, rapid pulse, chest…
As the nation’s attention turns toward the distribution of the COVID-19 vaccine, providers are seeing many pregnant patients engaging in unhealthy behaviors, such as drug and alcohol use, to cope with the stress of the pandemic. Across all demographics, mental health issues have increased with the added stress of the COVID-19 pandemic, according to a…
Norton Healthcare is making monoclonal antibody treatment Bamlanivimab available under the Food and Drug Administration’s emergency use authorization for certain patients at high risk for requiring hospitalization for COVID-19. We are fortunate to have extensive expertise in the development and utilization of monoclonal antibodies in the treatment of a wide array of diseases. Bamlanivimab is…
The University of Kentucky, in partnership with Baptist Health Lexington and Norton Healthcare in Louisville, has been selected as a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research study, called the ENSEMBLE trial, to evaluate Janssen’s investigational COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S. The Phase 3…
Under an emergency use authorization by the Food and Drug Administration (FDA), all Norton Healthcare providers can order convalescent plasma therapy for confirmed COVID-19 hospitalized patients with severe or critical symptoms. Norton Healthcare hospitals have been providing convalescent plasma to treat COVID-19 since early April under an FDA-approved extended access program. Until recently, only a…
Norton Healthcare will launch a COVID-19 Long-term Care Clinic for adult patients who continue to experience side effects after having battled the coronavirus. “Norton Healthcare has been a regional leader in caring for patients with COVID-19. From innovative treatments and clinical trials to community-based testing, we have been at the forefront of this pandemic,” said…
As patients continue to be diagnosed with COVID-19, the disease caused by the coronavirus, Norton Healthcare is looking for ways to help them overcome the infection. Norton Healthcare is the first in the world to enroll COVID-19 patients in two new clinical trials after becoming the first to participate in a randomized Phase 2 clinical…
More than 30 critically ill COVID-19 patients at Norton Healthcare have received convalescent plasma, an experimental treatment that began in mid-April. Some are still recovering, while many patients have been able to go home. Norton Healthcare physicians have been testing the treatment for COVID-19 that has shown promise in smaller studies around the world. The…
Patient safety is our top priority. Due to the COVID-19 pandemic, we have revised policies as needed to help stop the spread of infection. There have been policy changes that affect labor and delivery for pregnant patients. If you have patients who will deliver in the next month, please let them know of the changes…
Norton Healthcare pulmonologists have developed a protocol for treating COVID-19 patients with prone positioning before they need to be intubated. Using the prone position is common with intubated patients with acute respiratory distress syndrome (ARDS). The new protocol extends the treatment to those who are struggling for oxygen, but aren’t ready for a ventilator. For…
A COVID-19 patient at Norton Healthcare is the first in the world to participate in a randomized Phase 2 clinical study using low-dose selinexor. This oral drug, manufactured by Karyopharm Therapeutics Inc. and marketed as XPOVIO, is currently approved at higher doses by the U.S. Food and Drug Administration (FDA) as a treatment for cancer patients with relapsed or refractory multiple myeloma….